Hormetic effects of hormones, antihormones, and antidepressants on cancer cell growth in culture: In vivo correlates

被引:17
作者
Brandes, LJ
机构
[1] Canc Care Manitoba, Hematol Oncol Sect, Winnipeg, MB R3E 0V9, Canada
[2] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Pharmacol Therapeut, Winnipeg, MB, Canada
关键词
D O I
10.1080/10408440500246801
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Evidence is presented that the ability of hormones and antihormones to cause biphasic (hormetic) proliferative responses in cancer cells in vitro correlates with a similar effect of these substances in humans with cancer. Certain antidepressants also produce biphasic growth responses of cancer cells in vitro and stimulate cancer growth in rodents, correlating with an increased risk of breast and other cancers in some, but not all, epidemiological studies assessing early and/or late cancer incidence in patients on antidepressant drugs. The observation that certain drugs with biphasic effects on cancer cell growth in vitro may also produce an "up-down" effect on cancer growth in humans supports Calabrese's suggestion that the concept of the hormetic dose response must be taken seriously by toxicologists and regulators.
引用
收藏
页码:587 / 592
页数:6
相关论文
共 58 条
  • [1] Psychiatric disorders in cancer patients: Descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals
    Akechi, T
    Nakano, T
    Okamura, H
    Ueda, S
    Akizuki, N
    Nakanishi, T
    Yoshikawa, E
    Matsuki, H
    Hirabayashi, E
    Uchitomi, Y
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (05) : 188 - 194
  • [2] Hormesis - An inappropriate extrapolation from the specific to the universal
    Axelrod, D
    Burns, K
    Davis, D
    Von Larebeke, N
    [J]. INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 2004, 10 (03) : 335 - 339
  • [3] Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study
    Beiderbeck-Noll, AB
    Sturkenboom, MCJM
    van der Linden, PD
    Herings, RMC
    Hofman, A
    Coebergh, JWW
    Leutkens, HGM
    Stricker, BHC
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (01) : 98 - 105
  • [4] TAMOXIFEN WITHDRAWAL RESPONSE - REPORT OF A CASE
    BELANI, CP
    PEARL, P
    WHITLEY, NO
    AISNER, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (02) : 449 - 450
  • [5] BENDELE RA, 1992, CANCER RES, V52, P6931
  • [6] Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
  • [7] RESPONSE TO ANTIDEPRESSANTS AND CANCER - CAUSE FOR CONCERN
    BRANDES, LJ
    CHEANG, M
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (01) : 84 - 85
  • [8] ENHANCED CANCER GROWTH IN MICE ADMINISTERED DAILY HUMAN-EQUIVALENT DOSES OF SOME H-1-ANTIHISTAMINES - PREDICTIVE IN-VITRO CORRELATES
    BRANDES, LJ
    WARRINGTON, RC
    ARRON, RJ
    BOGDANOVIC, RP
    FANG, W
    QUEEN, GM
    STEIN, DA
    TONG, JG
    ZABORNIAK, CLF
    LABELLA, FS
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (10) : 770 - 775
  • [9] DEPRESSION, ANTIDEPRESSANT MEDICATION, AND CANCER
    BRANDES, LJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (11) : 1414 - 1415
  • [10] N,N-diethyl-2-[4(phenylmethyl)phenoxy] ethanamine (DPPE), a chemopotentiating and cytoprotective agent in clinical trials:: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs
    Brandes, LJ
    Queen, GM
    LaBella, FS
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (04) : 298 - 304